Omics for Bioprospecting and Drug Discovery from Bacteria and Microalgae

Area of Science:

• Microbiology
• Biotechnology
• Drug Discovery

Background:

• Bacteria and microalgae display significant variations influenced by their environment, making metabolite production unpredictable.
• Traditional bioprospecting methods are labor-intensive, costly, and inefficient.
• Next-generation sequencing (NGS) enables comprehensive genomic analysis of microbial communities and strains.

Purpose of the Study:

• To review the application of "omics" approaches in screening bacteria and microalgae for drug lead discovery.
• To highlight the integration of "omics" data with analytical chemistry.
• To emphasize the importance of bioinformatics and chemoinformatics in identifying novel microbial strains and drug leads.

Main Methods:

• Genomics, transcriptomics, proteomics, lipidomics, and metabolomics analyses.
• Pan-genomic analysis using next-generation sequencing (NGS).
• Integration of molecular biology techniques with analytical chemistry.

Main Results:

• Omics approaches provide a robust framework for analyzing microbial genomes, gene expression, and metabolic profiles.
• These methods facilitate the identification of secondary metabolite biosynthetic pathways.
• Combined "omics" and analytical chemistry approaches enhance the discovery of novel drug leads.

Conclusions:

• Omics technologies are powerful tools for bioprospecting bacteria and microalgae.
• Advances in bioinformatics and chemoinformatics are crucial for maximizing the potential of "omics" in drug discovery.
• This integrated approach accelerates the identification of novel microbial resources and therapeutic compounds.